| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Transformation, Neoplastic | 67 | 2023 | 2820 | 5.180 |
Why?
|
| Telomerase | 50 | 2015 | 741 | 3.680 |
Why?
|
| Neoplasms | 91 | 2023 | 22142 | 2.630 |
Why?
|
| Gene Expression Regulation, Neoplastic | 65 | 2023 | 8531 | 2.480 |
Why?
|
| Cell Line, Tumor | 123 | 2024 | 16954 | 2.340 |
Why?
|
| Oncogenes | 24 | 2023 | 1220 | 2.060 |
Why?
|
| Telomere | 30 | 2012 | 939 | 1.940 |
Why?
|
| Adaptor Proteins, Signal Transducing | 17 | 2022 | 2897 | 1.900 |
Why?
|
| Protein Phosphatase 2 | 15 | 2014 | 231 | 1.860 |
Why?
|
| Phosphoprotein Phosphatases | 10 | 2020 | 328 | 1.760 |
Why?
|
| Genomics | 29 | 2023 | 5829 | 1.660 |
Why?
|
| I-kappa B Kinase | 7 | 2014 | 249 | 1.550 |
Why?
|
| beta Catenin | 11 | 2016 | 1042 | 1.550 |
Why?
|
| ras Proteins | 12 | 2022 | 1055 | 1.440 |
Why?
|
| Genome, Human | 18 | 2021 | 4423 | 1.350 |
Why?
|
| Genes, Essential | 9 | 2023 | 185 | 1.330 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 10 | 2022 | 2871 | 1.330 |
Why?
|
| Ovarian Neoplasms | 18 | 2022 | 4872 | 1.310 |
Why?
|
| TNF Receptor-Associated Factor 2 | 4 | 2013 | 56 | 1.310 |
Why?
|
| Gene Amplification | 13 | 2023 | 1084 | 1.270 |
Why?
|
| Cell Proliferation | 45 | 2024 | 10423 | 1.230 |
Why?
|
| RNA Interference | 31 | 2023 | 2816 | 1.200 |
Why?
|
| Mice, Nude | 30 | 2022 | 3606 | 1.180 |
Why?
|
| Mutation | 60 | 2021 | 30004 | 1.180 |
Why?
|
| Proto-Oncogene Proteins | 17 | 2021 | 4513 | 1.170 |
Why?
|
| Signal Transduction | 64 | 2023 | 23419 | 1.170 |
Why?
|
| Drug Resistance, Neoplasm | 27 | 2021 | 5301 | 1.160 |
Why?
|
| Receptors, Androgen | 13 | 2022 | 1077 | 1.050 |
Why?
|
| MAP Kinase Signaling System | 11 | 2022 | 1480 | 1.010 |
Why?
|
| Tumor Suppressor Protein p53 | 19 | 2023 | 2915 | 0.980 |
Why?
|
| Antigens, Polyomavirus Transforming | 10 | 2014 | 257 | 0.970 |
Why?
|
| Antineoplastic Agents | 31 | 2021 | 13632 | 0.950 |
Why?
|
| Pancreatic Neoplasms | 12 | 2023 | 5366 | 0.930 |
Why?
|
| DNA-Binding Proteins | 38 | 2023 | 9567 | 0.930 |
Why?
|
| Animals | 167 | 2024 | 168089 | 0.920 |
Why?
|
| Cell Survival | 24 | 2022 | 5778 | 0.900 |
Why?
|
| RNA, Small Interfering | 32 | 2018 | 3412 | 0.890 |
Why?
|
| Neoplasm Proteins | 13 | 2021 | 3594 | 0.880 |
Why?
|
| Gene Dosage | 10 | 2017 | 1217 | 0.870 |
Why?
|
| Protein Kinase Inhibitors | 19 | 2021 | 5665 | 0.860 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 12 | 2022 | 1746 | 0.840 |
Why?
|
| Transcription Factors | 25 | 2022 | 12101 | 0.820 |
Why?
|
| Mice | 120 | 2024 | 81330 | 0.810 |
Why?
|
| RNA-Binding Proteins | 8 | 2022 | 1855 | 0.810 |
Why?
|
| Vaccinia | 1 | 2022 | 70 | 0.810 |
Why?
|
| Humans | 345 | 2024 | 761222 | 0.800 |
Why?
|
| Carcinoma, Medullary | 2 | 2021 | 115 | 0.800 |
Why?
|
| Alleles | 16 | 2021 | 6857 | 0.800 |
Why?
|
| Phosphoproteins | 8 | 2022 | 2444 | 0.780 |
Why?
|
| Peptide Library | 1 | 2022 | 347 | 0.760 |
Why?
|
| Smad4 Protein | 1 | 2021 | 191 | 0.700 |
Why?
|
| Carcinoma, Pancreatic Ductal | 9 | 2023 | 1726 | 0.690 |
Why?
|
| Cyclic AMP Response Element-Binding Protein A | 1 | 2019 | 21 | 0.680 |
Why?
|
| Fibroblasts | 17 | 2014 | 4138 | 0.680 |
Why?
|
| Androgen Receptor Antagonists | 3 | 2019 | 125 | 0.670 |
Why?
|
| Neuroblastoma | 4 | 2022 | 1246 | 0.670 |
Why?
|
| Epithelial-Mesenchymal Transition | 6 | 2021 | 736 | 0.660 |
Why?
|
| Adenocarcinoma | 15 | 2021 | 6341 | 0.650 |
Why?
|
| Death Domain Receptor Signaling Adaptor Proteins | 1 | 2019 | 33 | 0.650 |
Why?
|
| Simian virus 40 | 7 | 2014 | 291 | 0.640 |
Why?
|
| Prostatic Neoplasms | 26 | 2024 | 11101 | 0.640 |
Why?
|
| Gene Silencing | 8 | 2019 | 1495 | 0.640 |
Why?
|
| Neoplasms, Experimental | 8 | 2018 | 1225 | 0.640 |
Why?
|
| Ubiquitination | 5 | 2023 | 1005 | 0.630 |
Why?
|
| Breast Neoplasms | 23 | 2018 | 20982 | 0.630 |
Why?
|
| Genes, ras | 11 | 2017 | 654 | 0.620 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2021 | 582 | 0.620 |
Why?
|
| Gene Expression Profiling | 36 | 2023 | 9417 | 0.620 |
Why?
|
| Gene Knockout Techniques | 4 | 2021 | 801 | 0.620 |
Why?
|
| Enzyme Inhibitors | 6 | 2017 | 3702 | 0.620 |
Why?
|
| Cyclin-Dependent Kinase 8 | 4 | 2013 | 48 | 0.620 |
Why?
|
| DNA Damage | 10 | 2020 | 2443 | 0.600 |
Why?
|
| Phosphatidylinositol 3-Kinases | 14 | 2022 | 2864 | 0.580 |
Why?
|
| Apoptosis | 23 | 2024 | 9478 | 0.580 |
Why?
|
| Ketoglutarate Dehydrogenase Complex | 1 | 2017 | 21 | 0.570 |
Why?
|
| Urothelium | 2 | 2019 | 269 | 0.570 |
Why?
|
| Nuclear Proteins | 14 | 2018 | 5783 | 0.570 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 8 | 1993 | 897 | 0.560 |
Why?
|
| Neoplasm Transplantation | 12 | 2019 | 2010 | 0.560 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2019 | 1240 | 0.550 |
Why?
|
| NF-kappa B | 10 | 2014 | 2475 | 0.540 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 126 | 0.530 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2019 | 1318 | 0.530 |
Why?
|
| Proto-Oncogene Proteins B-raf | 15 | 2017 | 2054 | 0.530 |
Why?
|
| Cell Line | 32 | 2023 | 15545 | 0.530 |
Why?
|
| Colonic Neoplasms | 5 | 2022 | 2527 | 0.520 |
Why?
|
| Open Reading Frames | 8 | 2019 | 811 | 0.510 |
Why?
|
| Disease Models, Animal | 18 | 2022 | 18222 | 0.510 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 5 | 2022 | 899 | 0.500 |
Why?
|
| Oncogene Protein p21(ras) | 3 | 2014 | 68 | 0.500 |
Why?
|
| Genomic Instability | 3 | 2012 | 709 | 0.500 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2013 | 198 | 0.490 |
Why?
|
| Antigens, Viral, Tumor | 4 | 2007 | 153 | 0.490 |
Why?
|
| Cell Division | 22 | 2006 | 4451 | 0.480 |
Why?
|
| T-Box Domain Proteins | 2 | 2019 | 469 | 0.480 |
Why?
|
| Xenograft Model Antitumor Assays | 18 | 2022 | 3593 | 0.470 |
Why?
|
| Antigens, Protozoan | 1 | 2017 | 316 | 0.470 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2014 | 12 | 0.470 |
Why?
|
| Genes, Tumor Suppressor | 6 | 2012 | 1057 | 0.470 |
Why?
|
| Wnt Proteins | 3 | 2013 | 720 | 0.470 |
Why?
|
| Mutagenesis | 1 | 2018 | 1226 | 0.470 |
Why?
|
| Alternative Splicing | 2 | 2018 | 1087 | 0.460 |
Why?
|
| Urinary Bladder Neoplasms | 4 | 2019 | 2223 | 0.460 |
Why?
|
| Drug Synergism | 3 | 2017 | 1756 | 0.460 |
Why?
|
| Cells | 2 | 2021 | 164 | 0.460 |
Why?
|
| p21-Activated Kinases | 2 | 2011 | 127 | 0.440 |
Why?
|
| Gene Targeting | 3 | 2016 | 838 | 0.440 |
Why?
|
| Carcinoma | 2 | 2023 | 2330 | 0.440 |
Why?
|
| Epithelial Cells | 12 | 2012 | 3671 | 0.430 |
Why?
|
| Rhabdoid Tumor | 3 | 2020 | 210 | 0.430 |
Why?
|
| Phosphorylation | 22 | 2022 | 8300 | 0.430 |
Why?
|
| Gene Deletion | 7 | 2018 | 2658 | 0.430 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2023 | 1468 | 0.420 |
Why?
|
| Receptors, Immunologic | 8 | 1993 | 1408 | 0.420 |
Why?
|
| HEK293 Cells | 13 | 2020 | 4243 | 0.420 |
Why?
|
| raf Kinases | 4 | 2022 | 118 | 0.420 |
Why?
|
| Oncogene Proteins, Fusion | 9 | 2021 | 1605 | 0.420 |
Why?
|
| Mammary Glands, Human | 4 | 2019 | 202 | 0.410 |
Why?
|
| Proto-Oncogene Proteins c-akt | 13 | 2013 | 2455 | 0.410 |
Why?
|
| Oncogene Proteins | 7 | 2021 | 718 | 0.410 |
Why?
|
| Lung Neoplasms | 15 | 2022 | 13386 | 0.410 |
Why?
|
| Genome | 10 | 2023 | 1738 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-myc | 10 | 2019 | 987 | 0.400 |
Why?
|
| Repressor Proteins | 4 | 2022 | 2974 | 0.400 |
Why?
|
| Drug Delivery Systems | 3 | 2021 | 2223 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2013 | 322 | 0.400 |
Why?
|
| Immunoblotting | 10 | 2016 | 1644 | 0.400 |
Why?
|
| Cell Cycle Proteins | 13 | 2024 | 3446 | 0.390 |
Why?
|
| Telomere-Binding Proteins | 2 | 2011 | 118 | 0.390 |
Why?
|
| Proteins | 6 | 2021 | 5993 | 0.380 |
Why?
|
| Receptor, erbB-2 | 5 | 2017 | 2553 | 0.380 |
Why?
|
| Protein Kinases | 4 | 2017 | 1607 | 0.380 |
Why?
|
| Brain Neoplasms | 9 | 2017 | 9025 | 0.380 |
Why?
|
| Glioma | 4 | 2022 | 3452 | 0.380 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2018 | 3634 | 0.380 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2023 | 2549 | 0.380 |
Why?
|
| Quinazolines | 4 | 2014 | 1371 | 0.370 |
Why?
|
| Retinoblastoma Protein | 7 | 2017 | 671 | 0.370 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2014 | 487 | 0.370 |
Why?
|
| Cell Line, Transformed | 6 | 2011 | 864 | 0.370 |
Why?
|
| ral GTP-Binding Proteins | 2 | 2007 | 9 | 0.370 |
Why?
|
| RNA, Untranslated | 2 | 2011 | 453 | 0.360 |
Why?
|
| DNA Mutational Analysis | 14 | 2021 | 4107 | 0.360 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 8 | 2016 | 697 | 0.350 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2014 | 478 | 0.350 |
Why?
|
| DNA Copy Number Variations | 5 | 2017 | 2024 | 0.340 |
Why?
|
| HCT116 Cells | 5 | 2019 | 405 | 0.340 |
Why?
|
| Gene Library | 6 | 2021 | 1054 | 0.340 |
Why?
|
| Models, Biological | 11 | 2018 | 9458 | 0.340 |
Why?
|
| Epigenesis, Genetic | 7 | 2017 | 3788 | 0.340 |
Why?
|
| Cell Lineage | 7 | 2019 | 2549 | 0.340 |
Why?
|
| Genetic Predisposition to Disease | 12 | 2021 | 17897 | 0.340 |
Why?
|
| Thiazoles | 1 | 2017 | 1517 | 0.340 |
Why?
|
| Gene Expression | 12 | 2022 | 7571 | 0.330 |
Why?
|
| Genetic Vectors | 9 | 2011 | 3388 | 0.330 |
Why?
|
| Kidney Neoplasms | 3 | 2024 | 4251 | 0.330 |
Why?
|
| Oncogene Proteins, Viral | 2 | 2014 | 340 | 0.330 |
Why?
|
| Glioblastoma | 7 | 2014 | 3482 | 0.330 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2021 | 1892 | 0.320 |
Why?
|
| Molecular Targeted Therapy | 8 | 2021 | 2813 | 0.320 |
Why?
|
| Triazoles | 5 | 2024 | 902 | 0.320 |
Why?
|
| Colorectal Neoplasms | 9 | 2023 | 6919 | 0.320 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2021 | 212 | 0.320 |
Why?
|
| Genome-Wide Association Study | 9 | 2021 | 12676 | 0.320 |
Why?
|
| Protein Subunits | 7 | 2014 | 940 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2014 | 566 | 0.310 |
Why?
|
| Proteomics | 6 | 2020 | 3840 | 0.310 |
Why?
|
| Diploidy | 1 | 2008 | 133 | 0.310 |
Why?
|
| Computational Biology | 8 | 2024 | 3499 | 0.310 |
Why?
|
| Neoplasm Invasiveness | 7 | 2013 | 3590 | 0.310 |
Why?
|
| bcl-X Protein | 4 | 2020 | 410 | 0.310 |
Why?
|
| Suppression, Genetic | 1 | 2008 | 190 | 0.310 |
Why?
|
| Tumor Microenvironment | 5 | 2022 | 3875 | 0.310 |
Why?
|
| Janus Kinase 2 | 4 | 2018 | 559 | 0.300 |
Why?
|
| Cyclin-Dependent Kinases | 4 | 2019 | 655 | 0.300 |
Why?
|
| Protein-Arginine N-Methyltransferases | 3 | 2022 | 127 | 0.300 |
Why?
|
| Organoids | 5 | 2022 | 744 | 0.300 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 2 | 2024 | 81 | 0.300 |
Why?
|
| Enzyme Activation | 10 | 2011 | 3577 | 0.300 |
Why?
|
| Tumor Suppressor Proteins | 7 | 2012 | 2803 | 0.300 |
Why?
|
| Genes | 3 | 2024 | 1820 | 0.300 |
Why?
|
| Karyopherins | 4 | 2024 | 133 | 0.300 |
Why?
|
| Chordoma | 2 | 2023 | 347 | 0.300 |
Why?
|
| RNA | 9 | 2023 | 2709 | 0.300 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2018 | 1645 | 0.290 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 1031 | 0.290 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2024 | 318 | 0.290 |
Why?
|
| Base Sequence | 13 | 2018 | 12404 | 0.280 |
Why?
|
| Transcription, Genetic | 13 | 2018 | 7571 | 0.280 |
Why?
|
| Genetic Variation | 3 | 2018 | 6567 | 0.280 |
Why?
|
| Prostate | 6 | 2022 | 1772 | 0.280 |
Why?
|
| Cell Cycle | 9 | 2019 | 2926 | 0.270 |
Why?
|
| Drug Screening Assays, Antitumor | 5 | 2020 | 714 | 0.270 |
Why?
|
| Ubiquitins | 2 | 2023 | 366 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2019 | 367 | 0.260 |
Why?
|
| Benzamides | 5 | 2019 | 1371 | 0.260 |
Why?
|
| Female | 76 | 2022 | 392552 | 0.250 |
Why?
|
| Chromosome Mapping | 4 | 2022 | 4612 | 0.250 |
Why?
|
| Astrocytoma | 3 | 2017 | 774 | 0.250 |
Why?
|
| Janus Kinase 1 | 2 | 2018 | 107 | 0.250 |
Why?
|
| Tumor Cells, Cultured | 15 | 2021 | 6125 | 0.250 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 3 | 2015 | 305 | 0.250 |
Why?
|
| Transduction, Genetic | 4 | 2014 | 900 | 0.240 |
Why?
|
| Cyclin E | 3 | 2014 | 156 | 0.240 |
Why?
|
| NIH 3T3 Cells | 6 | 2012 | 667 | 0.240 |
Why?
|
| Cells, Cultured | 19 | 2018 | 18927 | 0.240 |
Why?
|
| Cholangiocarcinoma | 2 | 2021 | 554 | 0.240 |
Why?
|
| Cloning, Molecular | 5 | 2012 | 4167 | 0.230 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 3 | 2021 | 164 | 0.230 |
Why?
|
| Databases, Genetic | 6 | 2021 | 1741 | 0.230 |
Why?
|
| Hydrazines | 2 | 2024 | 222 | 0.230 |
Why?
|
| Protein Binding | 16 | 2022 | 9297 | 0.230 |
Why?
|
| Transcriptional Activation | 4 | 2022 | 1749 | 0.230 |
Why?
|
| Tumor Escape | 2 | 2021 | 371 | 0.230 |
Why?
|
| DNA Helicases | 5 | 2023 | 850 | 0.230 |
Why?
|
| Bone Neoplasms | 4 | 2023 | 2527 | 0.230 |
Why?
|
| Cyclin-Dependent Kinase 4 | 5 | 2019 | 559 | 0.230 |
Why?
|
| MAP Kinase Kinase Kinases | 3 | 2017 | 252 | 0.230 |
Why?
|
| Lentivirus | 4 | 2011 | 508 | 0.230 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2011 | 614 | 0.220 |
Why?
|
| DNA | 7 | 2018 | 7189 | 0.220 |
Why?
|
| Membrane Proteins | 3 | 2022 | 7851 | 0.220 |
Why?
|
| High-Throughput Screening Assays | 4 | 2017 | 929 | 0.220 |
Why?
|
| Pyrimidinones | 2 | 2017 | 385 | 0.220 |
Why?
|
| Chromatin | 7 | 2018 | 2946 | 0.220 |
Why?
|
| Thrombospondins | 1 | 2004 | 195 | 0.220 |
Why?
|
| Down-Regulation | 8 | 2019 | 2916 | 0.220 |
Why?
|
| Cyclin-Dependent Kinase 6 | 4 | 2019 | 348 | 0.220 |
Why?
|
| HeLa Cells | 14 | 2017 | 3073 | 0.220 |
Why?
|
| Membrane Glycoproteins | 5 | 2016 | 3696 | 0.220 |
Why?
|
| Retroviridae | 7 | 2012 | 850 | 0.210 |
Why?
|
| Ubiquitin | 2 | 2019 | 839 | 0.210 |
Why?
|
| Androgens | 5 | 2010 | 1283 | 0.210 |
Why?
|
| Gene Expression Regulation | 13 | 2020 | 11855 | 0.210 |
Why?
|
| Mice, SCID | 8 | 2019 | 2621 | 0.210 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2021 | 1360 | 0.210 |
Why?
|
| Melanoma | 10 | 2017 | 5694 | 0.210 |
Why?
|
| Cell Differentiation | 12 | 2023 | 11512 | 0.210 |
Why?
|
| Histones | 9 | 2019 | 2570 | 0.210 |
Why?
|
| Amino Acid Sequence | 14 | 2013 | 13402 | 0.210 |
Why?
|
| Protein Biosynthesis | 3 | 2020 | 2091 | 0.200 |
Why?
|
| Cell Transformation, Viral | 4 | 2014 | 526 | 0.200 |
Why?
|
| Gene Knockdown Techniques | 5 | 2020 | 1602 | 0.200 |
Why?
|
| Genetic Testing | 5 | 2018 | 3537 | 0.200 |
Why?
|
| Pyridones | 3 | 2017 | 809 | 0.200 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2009 | 782 | 0.200 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2024 | 855 | 0.200 |
Why?
|
| Molecular Biology | 2 | 2004 | 573 | 0.200 |
Why?
|
| Leukemia, Myeloid, Acute | 5 | 2019 | 3610 | 0.200 |
Why?
|
| Anoikis | 2 | 2014 | 50 | 0.200 |
Why?
|
| Multiple Myeloma | 5 | 2023 | 5145 | 0.200 |
Why?
|
| Protein Phosphatase 1 | 1 | 2022 | 134 | 0.200 |
Why?
|
| MAP Kinase Kinase 1 | 2 | 2015 | 332 | 0.190 |
Why?
|
| Homeodomain Proteins | 6 | 2016 | 2414 | 0.190 |
Why?
|
| Neovascularization, Pathologic | 4 | 2012 | 2636 | 0.190 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 4 | 2015 | 5321 | 0.190 |
Why?
|
| Molecular Sequence Data | 13 | 2014 | 17598 | 0.190 |
Why?
|
| Transplantation, Heterologous | 7 | 2017 | 2381 | 0.190 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2022 | 185 | 0.190 |
Why?
|
| Eukaryotic Cells | 1 | 2002 | 192 | 0.190 |
Why?
|
| Neoplastic Stem Cells | 2 | 2006 | 1348 | 0.190 |
Why?
|
| Urologic Neoplasms | 2 | 2016 | 314 | 0.190 |
Why?
|
| Wilms Tumor | 1 | 2024 | 376 | 0.190 |
Why?
|
| Transfection | 10 | 2010 | 5748 | 0.180 |
Why?
|
| Calmodulin | 1 | 2022 | 217 | 0.180 |
Why?
|
| Phenylthiohydantoin | 2 | 2019 | 205 | 0.180 |
Why?
|
| Antigens, CD | 6 | 1993 | 4009 | 0.180 |
Why?
|
| Vaccinia virus | 1 | 2022 | 329 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 7 | 2018 | 4739 | 0.180 |
Why?
|
| Root Canal Irrigants | 1 | 2000 | 15 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2014 | 4567 | 0.180 |
Why?
|
| Lysine | 3 | 2014 | 982 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 8 | 2014 | 3777 | 0.180 |
Why?
|
| Sodium Hypochlorite | 1 | 2000 | 31 | 0.180 |
Why?
|
| HT29 Cells | 2 | 2017 | 192 | 0.180 |
Why?
|
| Genes, Lethal | 2 | 2011 | 223 | 0.170 |
Why?
|
| Semantics | 1 | 2024 | 612 | 0.170 |
Why?
|
| Neoplasm Metastasis | 7 | 2021 | 4909 | 0.170 |
Why?
|
| Multiprotein Complexes | 3 | 2022 | 1112 | 0.170 |
Why?
|
| Antigens, Neoplasm | 3 | 2022 | 1985 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 7 | 2018 | 6200 | 0.170 |
Why?
|
| Drug Discovery | 4 | 2011 | 1048 | 0.170 |
Why?
|
| Exons | 5 | 2018 | 2380 | 0.170 |
Why?
|
| Population Dynamics | 1 | 2021 | 308 | 0.170 |
Why?
|
| Asparagine | 2 | 2019 | 120 | 0.170 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2019 | 2509 | 0.170 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2020 | 149 | 0.170 |
Why?
|
| Catalysis | 3 | 2017 | 763 | 0.160 |
Why?
|
| Nervous System | 1 | 2022 | 545 | 0.160 |
Why?
|
| Vacuolar Proton-Translocating ATPases | 1 | 2020 | 195 | 0.160 |
Why?
|
| Models, Genetic | 5 | 2018 | 3430 | 0.160 |
Why?
|
| Azepines | 2 | 2019 | 328 | 0.160 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2021 | 305 | 0.160 |
Why?
|
| Phenotype | 16 | 2023 | 16575 | 0.160 |
Why?
|
| Male | 56 | 2024 | 360703 | 0.160 |
Why?
|
| False Positive Reactions | 3 | 2017 | 958 | 0.160 |
Why?
|
| Reproducibility of Results | 10 | 2021 | 20118 | 0.160 |
Why?
|
| Fetal Proteins | 1 | 2019 | 98 | 0.160 |
Why?
|
| Protease Inhibitors | 2 | 2020 | 752 | 0.160 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2020 | 233 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2019 | 223 | 0.150 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2018 | 43 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2018 | 638 | 0.150 |
Why?
|
| Bronchi | 1 | 2002 | 843 | 0.150 |
Why?
|
| Cryoelectron Microscopy | 1 | 2022 | 643 | 0.150 |
Why?
|
| eIF-2 Kinase | 1 | 2018 | 145 | 0.150 |
Why?
|
| Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 48 | 0.150 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2014 | 410 | 0.150 |
Why?
|
| Germ-Line Mutation | 3 | 2021 | 1852 | 0.150 |
Why?
|
| Fusobacterium | 1 | 2017 | 53 | 0.150 |
Why?
|
| Translocation, Genetic | 2 | 2017 | 1391 | 0.150 |
Why?
|
| Indoles | 5 | 2015 | 1830 | 0.150 |
Why?
|
| T-Lymphocytes | 7 | 1995 | 10203 | 0.150 |
Why?
|
| Chromatin Assembly and Disassembly | 4 | 2018 | 634 | 0.140 |
Why?
|
| Protein Isoforms | 3 | 2018 | 1695 | 0.140 |
Why?
|
| Mass Spectrometry | 3 | 2011 | 2189 | 0.140 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1997 | 58 | 0.140 |
Why?
|
| Nitriles | 2 | 2019 | 971 | 0.140 |
Why?
|
| Microsatellite Instability | 2 | 2019 | 716 | 0.140 |
Why?
|
| 14-3-3 Proteins | 2 | 2010 | 220 | 0.140 |
Why?
|
| DNA Methylation | 8 | 2019 | 4384 | 0.140 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2014 | 943 | 0.140 |
Why?
|
| Genetic Fitness | 1 | 2018 | 118 | 0.140 |
Why?
|
| Chemokine CCL5 | 2 | 2014 | 214 | 0.140 |
Why?
|
| Disease Progression | 7 | 2024 | 13511 | 0.140 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2017 | 287 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 6 | 2013 | 4021 | 0.140 |
Why?
|
| Adenosine Deaminase | 1 | 2018 | 250 | 0.130 |
Why?
|
| ADP-Ribosylation Factor 1 | 1 | 2016 | 43 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 9 | 2 | 2021 | 67 | 0.130 |
Why?
|
| RNA, Messenger | 8 | 2018 | 12747 | 0.130 |
Why?
|
| Mouth Neoplasms | 4 | 2005 | 596 | 0.130 |
Why?
|
| Genotype | 8 | 2021 | 12985 | 0.130 |
Why?
|
| Lipid Peroxidation | 1 | 2017 | 271 | 0.130 |
Why?
|
| Cell Death | 4 | 2017 | 1676 | 0.130 |
Why?
|
| Models, Immunological | 1 | 2018 | 515 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 3 | 2019 | 2011 | 0.130 |
Why?
|
| Glutathione | 1 | 2019 | 581 | 0.130 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 1613 | 0.130 |
Why?
|
| Metronidazole | 1 | 2017 | 232 | 0.130 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2017 | 199 | 0.130 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2016 | 28 | 0.130 |
Why?
|
| Glutathione Peroxidase | 1 | 2017 | 258 | 0.130 |
Why?
|
| DNA Cleavage | 1 | 2016 | 56 | 0.130 |
Why?
|
| Up-Regulation | 6 | 2017 | 4111 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2012 | 361 | 0.130 |
Why?
|
| Citric Acid Cycle | 1 | 2017 | 231 | 0.130 |
Why?
|
| Catalytic Domain | 5 | 2019 | 702 | 0.130 |
Why?
|
| Atlases as Topic | 1 | 2017 | 247 | 0.130 |
Why?
|
| Cyclin D1 | 3 | 2009 | 451 | 0.130 |
Why?
|
| Cell Adhesion | 10 | 2016 | 3091 | 0.130 |
Why?
|
| Sirtuin 1 | 2 | 2015 | 246 | 0.130 |
Why?
|
| Mutation, Missense | 3 | 2022 | 2567 | 0.130 |
Why?
|
| Lymphoma, T-Cell | 1 | 2018 | 303 | 0.130 |
Why?
|
| Autocrine Communication | 2 | 2014 | 169 | 0.130 |
Why?
|
| Receptor, trkB | 1 | 2016 | 124 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 2 | 2012 | 92 | 0.130 |
Why?
|
| Bile Duct Neoplasms | 1 | 2021 | 607 | 0.130 |
Why?
|
| Genes, myc | 4 | 2009 | 390 | 0.120 |
Why?
|
| Goals | 1 | 2021 | 710 | 0.120 |
Why?
|
| Natural Language Processing | 1 | 2024 | 1163 | 0.120 |
Why?
|
| DNA Repair Enzymes | 1 | 2017 | 346 | 0.120 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 426 | 0.120 |
Why?
|
| Genetic Association Studies | 4 | 2021 | 2731 | 0.120 |
Why?
|
| Gene Regulatory Networks | 4 | 2018 | 1743 | 0.120 |
Why?
|
| Serine Endopeptidases | 2 | 2018 | 1022 | 0.120 |
Why?
|
| Haplotypes | 1 | 2021 | 2715 | 0.120 |
Why?
|
| Plasmids | 5 | 2011 | 2261 | 0.120 |
Why?
|
| Blotting, Southern | 3 | 2011 | 775 | 0.120 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2014 | 109 | 0.120 |
Why?
|
| G1 Phase | 2 | 2014 | 404 | 0.120 |
Why?
|
| Selection, Genetic | 1 | 2019 | 871 | 0.120 |
Why?
|
| G-Quadruplexes | 1 | 2017 | 143 | 0.120 |
Why?
|
| Sarcoma | 2 | 2016 | 1800 | 0.120 |
Why?
|
| Organoplatinum Compounds | 1 | 2016 | 407 | 0.120 |
Why?
|
| Binding Sites | 7 | 2022 | 5988 | 0.120 |
Why?
|
| Neuroendocrine Tumors | 1 | 2021 | 642 | 0.120 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2017 | 504 | 0.120 |
Why?
|
| Antibodies | 1 | 2022 | 2415 | 0.120 |
Why?
|
| Interferons | 3 | 2018 | 702 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-pim-1 | 1 | 2014 | 32 | 0.120 |
Why?
|
| Keratinocytes | 4 | 2005 | 790 | 0.120 |
Why?
|
| Protein Multimerization | 2 | 2017 | 974 | 0.120 |
Why?
|
| Protein Interaction Mapping | 1 | 2018 | 614 | 0.120 |
Why?
|
| Pyrimidines | 6 | 2019 | 3027 | 0.120 |
Why?
|
| Endonucleases | 1 | 2017 | 370 | 0.120 |
Why?
|
| HMGN1 Protein | 1 | 2014 | 27 | 0.120 |
Why?
|
| DNA, Complementary | 4 | 2010 | 1989 | 0.120 |
Why?
|
| International Cooperation | 1 | 2021 | 1423 | 0.120 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 586 | 0.110 |
Why?
|
| bcl-Associated Death Protein | 1 | 2014 | 102 | 0.110 |
Why?
|
| DNA Repair | 6 | 2020 | 2041 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 4 | 2019 | 5773 | 0.110 |
Why?
|
| G2 Phase | 1 | 2014 | 136 | 0.110 |
Why?
|
| Cluster Analysis | 3 | 2015 | 2706 | 0.110 |
Why?
|
| Nanoparticles | 2 | 2018 | 1959 | 0.110 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2014 | 103 | 0.110 |
Why?
|
| Medulloblastoma | 1 | 2019 | 677 | 0.110 |
Why?
|
| GATA6 Transcription Factor | 1 | 2013 | 50 | 0.110 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2015 | 651 | 0.110 |
Why?
|
| DNA, Neoplasm | 3 | 2014 | 1743 | 0.110 |
Why?
|
| Libraries | 2 | 2010 | 21 | 0.110 |
Why?
|
| MicroRNAs | 4 | 2019 | 3758 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2014 | 1681 | 0.110 |
Why?
|
| Cathepsins | 1 | 2014 | 241 | 0.110 |
Why?
|
| S Phase | 2 | 2019 | 423 | 0.110 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2013 | 1168 | 0.110 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2014 | 112 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-yes | 1 | 2012 | 16 | 0.110 |
Why?
|
| Immunohistochemistry | 6 | 2018 | 11067 | 0.110 |
Why?
|
| Software | 3 | 2018 | 4431 | 0.110 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2015 | 725 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 55 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2014 | 430 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2013 | 182 | 0.110 |
Why?
|
| Leukemia | 2 | 2015 | 1518 | 0.110 |
Why?
|
| Polyploidy | 1 | 2013 | 119 | 0.110 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2012 | 502 | 0.110 |
Why?
|
| Gene Duplication | 1 | 2014 | 314 | 0.100 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2014 | 270 | 0.100 |
Why?
|
| Glycolysis | 1 | 2017 | 836 | 0.100 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2012 | 17 | 0.100 |
Why?
|
| Oligopeptides | 1 | 2018 | 1179 | 0.100 |
Why?
|
| Mediator Complex | 1 | 2013 | 106 | 0.100 |
Why?
|
| Adenosine Triphosphate | 1 | 2019 | 1988 | 0.100 |
Why?
|
| DNA Primers | 3 | 2012 | 2814 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2010 | 2426 | 0.100 |
Why?
|
| Neurogenesis | 1 | 2019 | 862 | 0.100 |
Why?
|
| Acetylation | 4 | 2018 | 1050 | 0.100 |
Why?
|
| Boronic Acids | 2 | 2013 | 915 | 0.100 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2012 | 61 | 0.100 |
Why?
|
| Adenoma | 1 | 2023 | 2159 | 0.100 |
Why?
|
| Methyltransferases | 1 | 2015 | 364 | 0.100 |
Why?
|
| Hybridomas | 5 | 1993 | 443 | 0.100 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2012 | 112 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2012 | 412 | 0.100 |
Why?
|
| Clinical Trials as Topic | 3 | 2021 | 8002 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2010 | 53 | 0.100 |
Why?
|
| Nucleic Acids | 1 | 2014 | 186 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 3 | 2011 | 872 | 0.100 |
Why?
|
| Pyridines | 5 | 2016 | 2872 | 0.100 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2012 | 102 | 0.100 |
Why?
|
| src-Family Kinases | 2 | 2012 | 536 | 0.100 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2014 | 194 | 0.100 |
Why?
|
| Genetic Heterogeneity | 1 | 2015 | 734 | 0.100 |
Why?
|
| Qb-SNARE Proteins | 1 | 2011 | 34 | 0.100 |
Why?
|
| Pyrophosphatases | 1 | 2012 | 142 | 0.100 |
Why?
|
| SOS1 Protein | 1 | 2011 | 40 | 0.100 |
Why?
|
| Forecasting | 1 | 2021 | 2928 | 0.100 |
Why?
|
| Cyclic AMP | 3 | 1995 | 1462 | 0.100 |
Why?
|
| Antibody Affinity | 1 | 1992 | 246 | 0.100 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2012 | 163 | 0.090 |
Why?
|
| Serine | 3 | 2010 | 826 | 0.090 |
Why?
|
| Osteosarcoma | 1 | 2017 | 896 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2021 | 15920 | 0.090 |
Why?
|
| Genomic Library | 1 | 2011 | 188 | 0.090 |
Why?
|
| Endometrial Neoplasms | 2 | 2014 | 1366 | 0.090 |
Why?
|
| Arthritis, Experimental | 2 | 2003 | 291 | 0.090 |
Why?
|
| Immunoprecipitation | 3 | 2010 | 874 | 0.090 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2011 | 152 | 0.090 |
Why?
|
| Prostatic Secretory Proteins | 1 | 2010 | 24 | 0.090 |
Why?
|
| Craniopharyngioma | 1 | 2014 | 276 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2015 | 790 | 0.090 |
Why?
|
| Quinolines | 2 | 2014 | 764 | 0.090 |
Why?
|
| Antioxidants | 1 | 2019 | 1667 | 0.090 |
Why?
|
| Mice, Inbred NOD | 5 | 2014 | 1822 | 0.090 |
Why?
|
| Interferon Regulatory Factors | 1 | 2012 | 261 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2022 | 1249 | 0.090 |
Why?
|
| Herbal Medicine | 1 | 2010 | 37 | 0.090 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 656 | 0.090 |
Why?
|
| Rare Diseases | 1 | 2016 | 624 | 0.090 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2011 | 163 | 0.090 |
Why?
|
| Paired Box Transcription Factors | 1 | 2011 | 206 | 0.090 |
Why?
|
| Pyrazines | 2 | 2013 | 1202 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2011 | 346 | 0.090 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 682 | 0.090 |
Why?
|
| Phloroglucinol | 1 | 2010 | 6 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2010 | 10756 | 0.090 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2015 | 610 | 0.090 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2010 | 60 | 0.090 |
Why?
|
| Medicine, Chinese Traditional | 1 | 2010 | 73 | 0.090 |
Why?
|
| Models, Molecular | 4 | 2011 | 5406 | 0.090 |
Why?
|
| Astrocytes | 2 | 2016 | 1341 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 380 | 0.090 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 193 | 0.090 |
Why?
|
| Plants, Medicinal | 1 | 2010 | 165 | 0.090 |
Why?
|
| Neurofibromin 1 | 1 | 2011 | 190 | 0.090 |
Why?
|
| Nervous System Neoplasms | 1 | 2010 | 91 | 0.090 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2013 | 427 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2010 | 277 | 0.090 |
Why?
|
| Methylation | 4 | 2015 | 1070 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2009 | 71 | 0.080 |
Why?
|
| WT1 Proteins | 1 | 2010 | 184 | 0.080 |
Why?
|
| Blotting, Northern | 1 | 2011 | 1545 | 0.080 |
Why?
|
| Peptides | 4 | 2018 | 4353 | 0.080 |
Why?
|
| Melanocytes | 3 | 2014 | 509 | 0.080 |
Why?
|
| Interleukin-6 | 3 | 2014 | 3210 | 0.080 |
Why?
|
| Cysteine Endopeptidases | 1 | 2012 | 551 | 0.080 |
Why?
|
| Small Molecule Libraries | 3 | 2019 | 731 | 0.080 |
Why?
|
| Lymphocyte Activation | 6 | 2001 | 5478 | 0.080 |
Why?
|
| Radiation, Ionizing | 2 | 2013 | 252 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2001 | 1783 | 0.080 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2009 | 81 | 0.080 |
Why?
|
| Cell Nucleus | 5 | 2018 | 2881 | 0.080 |
Why?
|
| Azacitidine | 1 | 2011 | 336 | 0.080 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2010 | 94 | 0.080 |
Why?
|
| Autoantigens | 1 | 2014 | 888 | 0.080 |
Why?
|
| Uveal Neoplasms | 1 | 2012 | 341 | 0.080 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 620 | 0.080 |
Why?
|
| Time Factors | 11 | 2015 | 39957 | 0.080 |
Why?
|
| Neuregulin-1 | 1 | 2010 | 135 | 0.080 |
Why?
|
| Blotting, Western | 6 | 2012 | 5032 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 4404 | 0.080 |
Why?
|
| Research Support as Topic | 1 | 2013 | 697 | 0.080 |
Why?
|
| Collateral Circulation | 1 | 2010 | 293 | 0.080 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2015 | 937 | 0.080 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 143 | 0.080 |
Why?
|
| Receptor, erbB-3 | 1 | 2010 | 142 | 0.080 |
Why?
|
| RNA Polymerase II | 1 | 2013 | 537 | 0.080 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2009 | 99 | 0.080 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2009 | 112 | 0.080 |
Why?
|
| Breast | 2 | 2012 | 1964 | 0.080 |
Why?
|
| Mitosis | 3 | 2014 | 1187 | 0.080 |
Why?
|
| Recombination, Genetic | 2 | 2003 | 1518 | 0.080 |
Why?
|
| Phytotherapy | 1 | 2010 | 296 | 0.080 |
Why?
|
| RNA, Neoplasm | 1 | 2011 | 748 | 0.080 |
Why?
|
| Kidney | 3 | 2019 | 7033 | 0.080 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2010 | 169 | 0.080 |
Why?
|
| Heterochromatin | 1 | 2011 | 291 | 0.080 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2008 | 58 | 0.080 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2009 | 677 | 0.080 |
Why?
|
| Disease-Free Survival | 5 | 2018 | 6819 | 0.080 |
Why?
|
| Nanotechnology | 1 | 2014 | 713 | 0.080 |
Why?
|
| Cell Movement | 6 | 2020 | 5195 | 0.070 |
Why?
|
| Tumor Suppressor Protein p14ARF | 2 | 2005 | 84 | 0.070 |
Why?
|
| Stomach Neoplasms | 2 | 2019 | 1457 | 0.070 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2009 | 286 | 0.070 |
Why?
|
| Sialoglycoproteins | 2 | 2003 | 315 | 0.070 |
Why?
|
| Stem Cells | 2 | 2011 | 3517 | 0.070 |
Why?
|
| Endoribonucleases | 1 | 2009 | 227 | 0.070 |
Why?
|
| Chromosome Deletion | 1 | 2012 | 1386 | 0.070 |
Why?
|
| Sulfonamides | 3 | 2014 | 1977 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1625 | 0.070 |
Why?
|
| Blast Crisis | 1 | 2008 | 102 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 5 | 2013 | 3778 | 0.070 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2011 | 646 | 0.070 |
Why?
|
| Pyrazoles | 2 | 2015 | 2010 | 0.070 |
Why?
|
| Algorithms | 7 | 2021 | 14025 | 0.070 |
Why?
|
| Colon | 2 | 2012 | 1791 | 0.070 |
Why?
|
| Esophageal Neoplasms | 2 | 2009 | 1658 | 0.070 |
Why?
|
| Genes, p53 | 4 | 2003 | 713 | 0.070 |
Why?
|
| DNA Breaks, Double-Stranded | 3 | 2018 | 613 | 0.070 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 208 | 0.070 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2008 | 275 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 1002 | 0.070 |
Why?
|
| Imidazoles | 1 | 2013 | 1172 | 0.070 |
Why?
|
| BRCA1 Protein | 1 | 2013 | 1149 | 0.070 |
Why?
|
| Antigens, Surface | 1 | 1991 | 1607 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2011 | 946 | 0.070 |
Why?
|
| Ribonucleoproteins | 1 | 2009 | 356 | 0.070 |
Why?
|
| cdc25 Phosphatases | 1 | 2006 | 60 | 0.070 |
Why?
|
| Multigene Family | 2 | 2013 | 1075 | 0.070 |
Why?
|
| Pancreatic Ducts | 1 | 2008 | 329 | 0.070 |
Why?
|
| Inhibitory Concentration 50 | 4 | 2010 | 464 | 0.070 |
Why?
|
| Mice, Transgenic | 7 | 2018 | 9520 | 0.070 |
Why?
|
| Genetic Engineering | 3 | 2010 | 930 | 0.070 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2009 | 540 | 0.070 |
Why?
|
| Aminopyridines | 3 | 2019 | 573 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 9 | 2019 | 22128 | 0.070 |
Why?
|
| Solubility | 2 | 2005 | 1085 | 0.070 |
Why?
|
| Zebrafish | 2 | 2020 | 3000 | 0.070 |
Why?
|
| Feline panleukopenia virus | 1 | 1985 | 1 | 0.070 |
Why?
|
| Parvoviridae | 1 | 1985 | 7 | 0.070 |
Why?
|
| Trans-Activators | 2 | 2013 | 2846 | 0.060 |
Why?
|
| Karyotyping | 3 | 2002 | 1172 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2008 | 475 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 3 | 2017 | 7407 | 0.060 |
Why?
|
| Haploidy | 1 | 2005 | 126 | 0.060 |
Why?
|
| Research Design | 2 | 2011 | 6180 | 0.060 |
Why?
|
| Mice, Knockout | 7 | 2019 | 14392 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 636 | 0.060 |
Why?
|
| Prognosis | 5 | 2023 | 29688 | 0.060 |
Why?
|
| Arteries | 1 | 2010 | 1121 | 0.060 |
Why?
|
| Sirtuins | 1 | 2008 | 320 | 0.060 |
Why?
|
| Pituitary Neoplasms | 1 | 2014 | 1322 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2021 | 3434 | 0.060 |
Why?
|
| Precancerous Conditions | 2 | 2010 | 982 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 5 | 2015 | 6067 | 0.060 |
Why?
|
| Skin Neoplasms | 2 | 2011 | 5809 | 0.060 |
Why?
|
| Xenopus | 1 | 2006 | 709 | 0.060 |
Why?
|
| CDC2 Protein Kinase | 1 | 2005 | 212 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2012 | 2468 | 0.060 |
Why?
|
| DNA Replication | 3 | 2011 | 1415 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2024 | 9278 | 0.060 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 3057 | 0.060 |
Why?
|
| RNA Splicing | 2 | 2019 | 896 | 0.060 |
Why?
|
| Mitogens | 1 | 2004 | 229 | 0.060 |
Why?
|
| Meningioma | 1 | 2013 | 1216 | 0.060 |
Why?
|
| Lymph Nodes | 1 | 2015 | 3461 | 0.060 |
Why?
|
| Kinetics | 4 | 2003 | 6312 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2021 | 8998 | 0.060 |
Why?
|
| Doxorubicin | 2 | 2024 | 2224 | 0.060 |
Why?
|
| Cell Growth Processes | 3 | 2010 | 382 | 0.060 |
Why?
|
| Xenopus Proteins | 1 | 2006 | 433 | 0.060 |
Why?
|
| Genetic Techniques | 2 | 2023 | 428 | 0.060 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2006 | 422 | 0.060 |
Why?
|
| Medical Oncology | 1 | 2015 | 2320 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2011 | 3933 | 0.050 |
Why?
|
| Chromosomal Instability | 1 | 2004 | 178 | 0.050 |
Why?
|
| Agar | 1 | 2003 | 51 | 0.050 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 2 | 1993 | 67 | 0.050 |
Why?
|
| Interleukins | 1 | 2008 | 782 | 0.050 |
Why?
|
| Child | 7 | 2022 | 80154 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2009 | 3726 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2015 | 6486 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2012 | 2194 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2003 | 310 | 0.050 |
Why?
|
| Cell Culture Techniques | 3 | 2009 | 1662 | 0.050 |
Why?
|
| Adult | 18 | 2021 | 221120 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2013 | 2019 | 0.050 |
Why?
|
| Piperazines | 3 | 2016 | 2522 | 0.050 |
Why?
|
| Protein Array Analysis | 2 | 2019 | 399 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2024 | 430 | 0.050 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2003 | 283 | 0.050 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 1933 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2003 | 812 | 0.050 |
Why?
|
| Electroporation | 1 | 2003 | 233 | 0.050 |
Why?
|
| Sirolimus | 1 | 2009 | 1540 | 0.050 |
Why?
|
| Middle Aged | 16 | 2021 | 220858 | 0.050 |
Why?
|
| 3T3 Cells | 2 | 2014 | 1083 | 0.050 |
Why?
|
| Claudins | 1 | 2023 | 117 | 0.050 |
Why?
|
| B-Lymphocytes | 2 | 2014 | 4744 | 0.050 |
Why?
|
| HLA-A3 Antigen | 1 | 2001 | 34 | 0.050 |
Why?
|
| Genes, Neoplasm | 2 | 2016 | 370 | 0.050 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2003 | 242 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2018 | 1334 | 0.050 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2010 | 915 | 0.050 |
Why?
|
| Guanosine Triphosphate | 1 | 2022 | 314 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1993 | 818 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2018 | 11733 | 0.050 |
Why?
|
| Aged | 14 | 2021 | 169292 | 0.050 |
Why?
|
| Ischemia | 1 | 2010 | 1889 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 4340 | 0.050 |
Why?
|
| DNA Breaks | 1 | 2021 | 47 | 0.050 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2013 | 473 | 0.050 |
Why?
|
| Genes, Immediate-Early | 1 | 2001 | 102 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 4 | 2014 | 2635 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2013 | 3923 | 0.050 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2002 | 117 | 0.050 |
Why?
|
| Genes, Overlapping | 1 | 2021 | 36 | 0.050 |
Why?
|
| Radiation Tolerance | 1 | 2003 | 478 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2010 | 2623 | 0.050 |
Why?
|
| Genes, RAG-1 | 1 | 2001 | 67 | 0.050 |
Why?
|
| Inositol | 1 | 2022 | 215 | 0.050 |
Why?
|
| Sequence Alignment | 3 | 2011 | 2175 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 585 | 0.050 |
Why?
|
| Chile | 1 | 2021 | 256 | 0.050 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2008 | 926 | 0.050 |
Why?
|
| Cyclins | 1 | 2003 | 594 | 0.050 |
Why?
|
| Immunoglobulin G | 2 | 2022 | 4537 | 0.050 |
Why?
|
| Oral Hemorrhage | 1 | 2000 | 24 | 0.040 |
Why?
|
| Homeostasis | 3 | 2011 | 3322 | 0.040 |
Why?
|
| Subcutaneous Emphysema | 1 | 2000 | 15 | 0.040 |
Why?
|
| U937 Cells | 2 | 2012 | 260 | 0.040 |
Why?
|
| Antibodies, Viral | 2 | 2022 | 3149 | 0.040 |
Why?
|
| Protein Stability | 1 | 2022 | 579 | 0.040 |
Why?
|
| Integrins | 2 | 2021 | 835 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2019 | 1892 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 256 | 0.040 |
Why?
|
| HL-60 Cells | 2 | 2012 | 363 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 1126 | 0.040 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 2 | 2014 | 258 | 0.040 |
Why?
|
| Mice, Hairless | 1 | 2019 | 39 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2004 | 1084 | 0.040 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 455 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2022 | 924 | 0.040 |
Why?
|
| Eye Burns | 1 | 2000 | 65 | 0.040 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2000 | 101 | 0.040 |
Why?
|
| Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor | 1 | 2019 | 11 | 0.040 |
Why?
|
| Molecular Structure | 2 | 2020 | 1875 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 1404 | 0.040 |
Why?
|
| Buthionine Sulfoximine | 1 | 2019 | 17 | 0.040 |
Why?
|
| Glutamate-Cysteine Ligase | 1 | 2019 | 23 | 0.040 |
Why?
|
| Ovary | 1 | 2004 | 957 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2019 | 98 | 0.040 |
Why?
|
| Blood-Brain Barrier | 2 | 2017 | 1028 | 0.040 |
Why?
|
| Ubiquitinated Proteins | 1 | 2019 | 32 | 0.040 |
Why?
|
| Adenosine Triphosphatases | 2 | 2014 | 833 | 0.040 |
Why?
|
| Burns, Chemical | 1 | 2000 | 123 | 0.040 |
Why?
|
| Thiocyanates | 1 | 2019 | 70 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2022 | 4574 | 0.040 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2012 | 380 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 3 | 2015 | 2062 | 0.040 |
Why?
|
| Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2014 | 430 | 0.040 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2018 | 74 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2022 | 642 | 0.040 |
Why?
|
| Kynurenine | 1 | 2019 | 141 | 0.040 |
Why?
|
| DNA, Viral | 1 | 1985 | 2195 | 0.040 |
Why?
|
| Peru | 1 | 2021 | 888 | 0.040 |
Why?
|
| Phosphates | 1 | 2022 | 763 | 0.040 |
Why?
|
| Immune Evasion | 1 | 2022 | 364 | 0.040 |
Why?
|
| Genetic Complementation Test | 2 | 2014 | 556 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2010 | 3044 | 0.040 |
Why?
|
| Artifacts | 1 | 2007 | 1912 | 0.040 |
Why?
|
| Morpholines | 2 | 2013 | 581 | 0.040 |
Why?
|
| Viral Proteins | 1 | 1985 | 1798 | 0.040 |
Why?
|
| Gene Rearrangement | 2 | 2015 | 1125 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2011 | 4935 | 0.040 |
Why?
|
| Rats | 5 | 2020 | 23705 | 0.040 |
Why?
|
| Biological Assay | 1 | 2021 | 623 | 0.040 |
Why?
|
| Cell Nucleolus | 2 | 2011 | 153 | 0.040 |
Why?
|
| Prevotella | 1 | 2017 | 80 | 0.040 |
Why?
|
| Depsipeptides | 1 | 2018 | 95 | 0.040 |
Why?
|
| Virus Replication | 1 | 2005 | 2426 | 0.040 |
Why?
|
| K562 Cells | 1 | 2019 | 640 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2023 | 1141 | 0.040 |
Why?
|
| Asparaginase | 1 | 2019 | 239 | 0.040 |
Why?
|
| Gingival Hyperplasia | 1 | 1997 | 19 | 0.040 |
Why?
|
| Lipid Peroxides | 1 | 2017 | 74 | 0.040 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2017 | 67 | 0.040 |
Why?
|
| Microarray Analysis | 2 | 2013 | 748 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2018 | 314 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2019 | 272 | 0.040 |
Why?
|
| Bacteroides | 1 | 2017 | 165 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 2 | 1995 | 1603 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2013 | 41496 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2004 | 1405 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2012 | 1768 | 0.030 |
Why?
|
| Ikaros Transcription Factor | 1 | 2018 | 232 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 2019 | 850 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2000 | 731 | 0.030 |
Why?
|
| Thionucleosides | 1 | 2016 | 13 | 0.030 |
Why?
|
| Pharmacogenetics | 2 | 2012 | 675 | 0.030 |
Why?
|
| Deoxyadenosines | 1 | 2016 | 27 | 0.030 |
Why?
|
| Cell Transdifferentiation | 1 | 2017 | 186 | 0.030 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 1999 | 621 | 0.030 |
Why?
|
| Cancer Vaccines | 1 | 2004 | 1038 | 0.030 |
Why?
|
| Models, Animal | 1 | 2002 | 2114 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2019 | 529 | 0.030 |
Why?
|
| Maximum Tolerated Dose | 1 | 2018 | 883 | 0.030 |
Why?
|
| Crystallography, X-Ray | 2 | 2013 | 1978 | 0.030 |
Why?
|
| Microscopy | 1 | 2021 | 904 | 0.030 |
Why?
|
| Albumins | 1 | 2018 | 575 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2018 | 10088 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2018 | 859 | 0.030 |
Why?
|
| Receptors, Purinergic P2Y | 1 | 2015 | 23 | 0.030 |
Why?
|
| Epigenomics | 1 | 2021 | 944 | 0.030 |
Why?
|
| Interleukin-2 | 2 | 1992 | 1891 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2014 | 5871 | 0.030 |
Why?
|
| Frozen Sections | 1 | 2015 | 153 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2012 | 1186 | 0.030 |
Why?
|
| Cystatins | 1 | 2014 | 55 | 0.030 |
Why?
|
| Oxidative Stress | 3 | 2019 | 3114 | 0.030 |
Why?
|
| Benzocycloheptenes | 1 | 2014 | 7 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 510 | 0.030 |
Why?
|
| Drug Design | 1 | 1999 | 1044 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 2 | 2010 | 1703 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 2015 | 241 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2018 | 2263 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2016 | 352 | 0.030 |
Why?
|
| United States | 4 | 2021 | 72341 | 0.030 |
Why?
|
| Mesoderm | 1 | 2017 | 673 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2014 | 240 | 0.030 |
Why?
|
| Chromosomes | 1 | 2017 | 579 | 0.030 |
Why?
|
| Cell Communication | 2 | 2008 | 1651 | 0.030 |
Why?
|
| Intestines | 1 | 2023 | 1908 | 0.030 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2014 | 181 | 0.030 |
Why?
|
| Deoxycytidine | 1 | 2018 | 878 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 64681 | 0.030 |
Why?
|
| Spleen Focus-Forming Viruses | 1 | 1993 | 16 | 0.030 |
Why?
|
| Adolescent | 6 | 2022 | 88300 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2014 | 227 | 0.030 |
Why?
|
| Friend murine leukemia virus | 1 | 1993 | 37 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2021 | 58952 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2014 | 249 | 0.030 |
Why?
|
| Rosette Formation | 1 | 1993 | 152 | 0.030 |
Why?
|
| Bucladesine | 1 | 1993 | 118 | 0.030 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2013 | 42 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1993 | 416 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2018 | 811 | 0.030 |
Why?
|
| Young Adult | 5 | 2021 | 59222 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2014 | 210 | 0.030 |
Why?
|
| Pyrrolidinones | 1 | 2013 | 116 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2019 | 1132 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2022 | 1408 | 0.030 |
Why?
|
| GATA4 Transcription Factor | 1 | 2013 | 124 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 2802 | 0.030 |
Why?
|
| Animals, Genetically Modified | 2 | 2008 | 1559 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 1331 | 0.030 |
Why?
|
| Human papillomavirus 16 | 1 | 2014 | 267 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 848 | 0.030 |
Why?
|
| Genes, erbB-1 | 1 | 2013 | 162 | 0.030 |
Why?
|
| Serpins | 1 | 2014 | 247 | 0.030 |
Why?
|
| Neurons | 2 | 2017 | 9429 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1993 | 849 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2018 | 1187 | 0.030 |
Why?
|
| Mammals | 1 | 2018 | 1129 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 14675 | 0.030 |
Why?
|
| Tyrphostins | 1 | 2012 | 63 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 2019 | 4310 | 0.030 |
Why?
|
| Cadherins | 1 | 2017 | 902 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2018 | 1525 | 0.030 |
Why?
|
| TYK2 Kinase | 1 | 2012 | 38 | 0.030 |
Why?
|
| Mice, Inbred DBA | 2 | 2003 | 623 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2009 | 1518 | 0.030 |
Why?
|
| HLA-A2 Antigen | 2 | 2004 | 209 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2021 | 1129 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2014 | 782 | 0.030 |
Why?
|
| Gentamicins | 1 | 1993 | 244 | 0.030 |
Why?
|
| Remission Induction | 1 | 2018 | 2392 | 0.030 |
Why?
|
| Janus Kinase 3 | 1 | 2012 | 77 | 0.020 |
Why?
|
| Gene Transfer Techniques | 2 | 2010 | 1201 | 0.020 |
Why?
|
| Metabolome | 1 | 2019 | 989 | 0.020 |
Why?
|
| Subcutaneous Tissue | 1 | 2012 | 132 | 0.020 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 886 | 0.020 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2013 | 141 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1935 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 704 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2012 | 188 | 0.020 |
Why?
|
| Technology, Pharmaceutical | 1 | 2012 | 84 | 0.020 |
Why?
|
| Neurofibromin 2 | 1 | 2013 | 269 | 0.020 |
Why?
|
| Cytotoxins | 1 | 2012 | 153 | 0.020 |
Why?
|
| Microscopy, Confocal | 2 | 2010 | 1967 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2012 | 147 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2003 | 9187 | 0.020 |
Why?
|
| Genes, p16 | 2 | 2003 | 160 | 0.020 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2011 | 8 | 0.020 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2014 | 419 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2011 | 394 | 0.020 |
Why?
|
| Wiskott-Aldrich Syndrome | 1 | 1991 | 131 | 0.020 |
Why?
|
| Inositol Phosphates | 1 | 1991 | 175 | 0.020 |
Why?
|
| Cyclin T | 1 | 2010 | 19 | 0.020 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 2010 | 16 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 781 | 0.020 |
Why?
|
| Materia Medica | 1 | 2010 | 14 | 0.020 |
Why?
|
| Anilides | 1 | 2014 | 411 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1993 | 457 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2018 | 1730 | 0.020 |
Why?
|
| Inflammation | 1 | 2010 | 10759 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2000 | 1167 | 0.020 |
Why?
|
| Dimerization | 1 | 2012 | 887 | 0.020 |
Why?
|
| Microscopy, Phase-Contrast | 1 | 2010 | 110 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 450 | 0.020 |
Why?
|
| Glycoproteins | 2 | 1989 | 2203 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2014 | 486 | 0.020 |
Why?
|
| Ribonucleases | 1 | 2011 | 264 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2452 | 0.020 |
Why?
|
| Sheep | 1 | 1993 | 1436 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 1520 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39127 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2010 | 205 | 0.020 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2001 | 2667 | 0.020 |
Why?
|
| Cisplatin | 1 | 2016 | 1652 | 0.020 |
Why?
|
| E-Box Elements | 1 | 2009 | 20 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 1992 | 574 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 6504 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2018 | 54437 | 0.020 |
Why?
|
| Plasminogen Inactivators | 1 | 1989 | 37 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2009 | 2058 | 0.020 |
Why?
|
| Interleukin-1 | 2 | 2003 | 1250 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2009 | 108 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2014 | 1963 | 0.020 |
Why?
|
| Child, Preschool | 4 | 2021 | 42225 | 0.020 |
Why?
|
| Cricetinae | 1 | 1993 | 2412 | 0.020 |
Why?
|
| Allosteric Regulation | 1 | 2010 | 424 | 0.020 |
Why?
|
| Mouth Mucosa | 2 | 2005 | 432 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 1992 | 684 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2009 | 103 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2010 | 296 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 316 | 0.020 |
Why?
|
| Castration | 1 | 2008 | 150 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2018 | 2465 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2014 | 858 | 0.020 |
Why?
|
| Iron | 1 | 2017 | 1791 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2009 | 310 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 1129 | 0.020 |
Why?
|
| Calcium | 2 | 2008 | 5719 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 550 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 1993 | 1169 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1993 | 1202 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 2012 | 836 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2010 | 557 | 0.020 |
Why?
|
| SEER Program | 1 | 2013 | 1453 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2010 | 330 | 0.020 |
Why?
|
| RNA, Double-Stranded | 1 | 2009 | 290 | 0.020 |
Why?
|
| Codon | 1 | 2009 | 597 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1992 | 1498 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2010 | 597 | 0.020 |
Why?
|
| Molecular Chaperones | 1 | 2012 | 754 | 0.020 |
Why?
|
| Introns | 1 | 2010 | 968 | 0.020 |
Why?
|
| Antigens, CD1 | 1 | 2010 | 439 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2009 | 267 | 0.020 |
Why?
|
| Risk | 2 | 2012 | 9616 | 0.020 |
Why?
|
| Leucine | 1 | 2009 | 546 | 0.020 |
Why?
|
| Flavonoids | 1 | 2010 | 444 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2008 | 230 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8642 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 1762 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2021 | 12341 | 0.020 |
Why?
|
| Oxazines | 1 | 2009 | 349 | 0.020 |
Why?
|
| Dioxygenases | 1 | 2009 | 346 | 0.020 |
Why?
|
| Holoenzymes | 1 | 2006 | 39 | 0.020 |
Why?
|
| Metribolone | 1 | 2006 | 13 | 0.020 |
Why?
|
| Fibrosarcoma | 1 | 2009 | 308 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2008 | 826 | 0.020 |
Why?
|
| Staurosporine | 1 | 2008 | 241 | 0.020 |
Why?
|
| Phosphothreonine | 1 | 2006 | 62 | 0.020 |
Why?
|
| Pentacyclic Triterpenes | 1 | 2006 | 35 | 0.020 |
Why?
|
| Limonins | 1 | 2006 | 24 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2009 | 463 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 1498 | 0.020 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 2006 | 38 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2001 | 1351 | 0.020 |
Why?
|
| CpG Islands | 1 | 2011 | 1190 | 0.020 |
Why?
|
| Acute Disease | 1 | 1997 | 7226 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2013 | 3603 | 0.020 |
Why?
|
| Interphase | 1 | 2006 | 227 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 1992 | 1553 | 0.020 |
Why?
|
| Triterpenes | 1 | 2006 | 76 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2014 | 2692 | 0.020 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2006 | 120 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 1838 | 0.020 |
Why?
|
| Intermediate Filaments | 1 | 2006 | 171 | 0.020 |
Why?
|
| Minute virus of mice | 1 | 1985 | 5 | 0.020 |
Why?
|
| Parvovirus | 1 | 1985 | 4 | 0.020 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2005 | 46 | 0.020 |
Why?
|
| Benzoquinones | 1 | 2006 | 198 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2005 | 115 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 775 | 0.020 |
Why?
|
| Cyclin A | 1 | 2005 | 60 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2014 | 2329 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 1737 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 2006 | 195 | 0.020 |
Why?
|
| Cyclin B1 | 1 | 2005 | 57 | 0.020 |
Why?
|
| Cyclin B | 1 | 2005 | 104 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2008 | 1150 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 2011 | 1134 | 0.020 |
Why?
|
| Transgenes | 1 | 2008 | 1008 | 0.020 |
Why?
|
| Keratins | 1 | 2006 | 498 | 0.020 |
Why?
|
| Tyrosine | 1 | 2009 | 1422 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12052 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2008 | 638 | 0.020 |
Why?
|
| Blood Coagulation | 1 | 2011 | 1156 | 0.020 |
Why?
|
| Extremities | 1 | 2010 | 867 | 0.010 |
Why?
|
| Lactams, Macrocyclic | 1 | 2006 | 318 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2006 | 739 | 0.010 |
Why?
|
| China | 1 | 2010 | 2374 | 0.010 |
Why?
|
| Genes, cdc | 1 | 2004 | 114 | 0.010 |
Why?
|
| Granulocytes | 1 | 2006 | 550 | 0.010 |
Why?
|
| Deoxyribonucleases | 1 | 1985 | 209 | 0.010 |
Why?
|
| Endothelium | 1 | 1987 | 763 | 0.010 |
Why?
|
| Survival Rate | 2 | 2010 | 12728 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2010 | 11119 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 2113 | 0.010 |
Why?
|
| Rabbits | 1 | 2010 | 4750 | 0.010 |
Why?
|
| Corpus Luteum | 1 | 2004 | 81 | 0.010 |
Why?
|
| Cystadenoma | 1 | 2004 | 79 | 0.010 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2004 | 97 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 1993 | 2049 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2012 | 3155 | 0.010 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 411 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 1111 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 1506 | 0.010 |
Why?
|
| Threonine | 1 | 2004 | 270 | 0.010 |
Why?
|
| Necrosis | 1 | 2007 | 1610 | 0.010 |
Why?
|
| Densitometry | 1 | 2003 | 151 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 189 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2018 | 4642 | 0.010 |
Why?
|
| Melanoma, Experimental | 1 | 2006 | 561 | 0.010 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2006 | 496 | 0.010 |
Why?
|
| Fluoresceins | 1 | 2003 | 235 | 0.010 |
Why?
|
| Biopsy | 1 | 2014 | 6781 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 564 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2003 | 555 | 0.010 |
Why?
|
| Piperidines | 1 | 2010 | 1656 | 0.010 |
Why?
|
| Species Specificity | 1 | 2006 | 2406 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8663 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 613 | 0.010 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2003 | 299 | 0.010 |
Why?
|
| RNA Stability | 1 | 2004 | 317 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 2740 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 4243 | 0.010 |
Why?
|
| Autophagy | 1 | 2009 | 1327 | 0.010 |
Why?
|
| Hindlimb | 1 | 2003 | 513 | 0.010 |
Why?
|
| RecQ Helicases | 1 | 2001 | 53 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 2004 | 872 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2003 | 578 | 0.010 |
Why?
|
| Internet | 1 | 2012 | 3096 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 1963 | 0.010 |
Why?
|
| Rad51 Recombinase | 1 | 2001 | 189 | 0.010 |
Why?
|
| Culture Media | 1 | 2002 | 894 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 1728 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 834 | 0.010 |
Why?
|
| Receptor, Notch1 | 1 | 2002 | 497 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 680 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 12474 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15308 | 0.010 |
Why?
|
| HLA-A Antigens | 1 | 1999 | 223 | 0.010 |
Why?
|
| Mouth | 1 | 2001 | 380 | 0.010 |
Why?
|
| Presenilin-1 | 1 | 2002 | 660 | 0.010 |
Why?
|
| Cell Separation | 1 | 2004 | 1721 | 0.010 |
Why?
|
| Cerebellum | 1 | 2005 | 1501 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2001 | 822 | 0.010 |
Why?
|
| Leukoedema, Oral | 1 | 1977 | 1 | 0.010 |
Why?
|
| Heterozygote | 1 | 2004 | 2778 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 1989 | 278 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2003 | 1668 | 0.010 |
Why?
|
| Proteome | 1 | 2007 | 1856 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 1970 | 3089 | 0.010 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2001 | 548 | 0.010 |
Why?
|
| Leukoplakia, Oral | 1 | 1977 | 77 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3803 | 0.010 |
Why?
|
| Lichen Planus | 1 | 1977 | 70 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 4921 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1989 | 2171 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20588 | 0.010 |
Why?
|
| Tongue Neoplasms | 1 | 1977 | 183 | 0.010 |
Why?
|
| Receptor Aggregation | 1 | 1995 | 72 | 0.010 |
Why?
|
| Membrane Fluidity | 1 | 1995 | 67 | 0.010 |
Why?
|
| Vaccines | 1 | 2004 | 835 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1970 | 6392 | 0.010 |
Why?
|
| Insulin | 1 | 1970 | 6588 | 0.010 |
Why?
|
| Epitopes | 1 | 2001 | 2504 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 1970 | 3417 | 0.010 |
Why?
|
| Collagen | 1 | 2003 | 2635 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2003 | 1901 | 0.010 |
Why?
|
| Mouth Diseases | 1 | 1977 | 240 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1995 | 340 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2001 | 1838 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8519 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2000 | 2138 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2010 | 22174 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2003 | 2726 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2001 | 1830 | 0.010 |
Why?
|
| Macrophages | 1 | 2006 | 5755 | 0.010 |
Why?
|
| Oxygen | 1 | 2002 | 4228 | 0.010 |
Why?
|
| Glucose | 1 | 2002 | 4342 | 0.010 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 1991 | 379 | 0.010 |
Why?
|
| HLA-DR Antigens | 1 | 1991 | 606 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2001 | 3390 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2001 | 5103 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 7386 | 0.000 |
Why?
|
| Infant | 1 | 2010 | 36170 | 0.000 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 1991 | 1128 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 36415 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2016 | 80675 | 0.000 |
Why?
|
| Sulfur Radioisotopes | 1 | 1987 | 113 | 0.000 |
Why?
|
| Ligands | 1 | 1991 | 3264 | 0.000 |
Why?
|
| Methionine | 1 | 1987 | 570 | 0.000 |
Why?
|
| Biological Evolution | 1 | 1989 | 1075 | 0.000 |
Why?
|
| Risk Factors | 1 | 2010 | 74241 | 0.000 |
Why?
|
| Fibronectins | 1 | 1987 | 724 | 0.000 |
Why?
|
| Hypoglycemia | 1 | 1970 | 883 | 0.000 |
Why?
|
| Epithelium | 1 | 1987 | 1603 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1977 | 12976 | 0.000 |
Why?
|
| Smoking | 1 | 1977 | 9055 | 0.000 |
Why?
|
| Diabetes Mellitus | 1 | 1970 | 5842 | 0.000 |
Why?
|
| Obesity | 1 | 1970 | 12940 | 0.000 |
Why?
|